Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.00

+8.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (6253)	4/30/2002 11:21:39 PM
From: Biomaven	Read Replies (2) of 52153

<OT> IJ, Seems like it would be easy enough to structure a line of credit so that it wouldn't fall under the FASB definition. I figure any collapse of the commercial paper market is probably good for the big banks - they are the ones that would replace this market. Incidentally, what do you think would be the consequences of the passage of the new bankruptcy bill now before Congress? Presumably good for the issuers of low-grade credit? If you are right that the volume of collections might be leveling off, then maybe the banks that are heavy credit cards issuers might be a decent speculation - these would be a play on the bankruptcy legislation as well. I guess American Express might be another decent play along the same lines. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next